Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zina Itkin

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Journal of Biomolecular Screening|August 21, 2012
Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compoundsThomas Smith, Pei-I Ho, Kim Yue, et al.
Frontiers in Pharmacology|December 12, 2022
Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule librariesMichael H Ronzetti, Bolormaa Baljinnyam, Zina Itkin, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug DiscoveryXin Hu, Paul Shinn, Zina Itkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2021
Deep learning identifies synergistic drug combinations for treating COVID-19Wengong Jin, Jonathan M Stokes, Richard T Eastman, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 9, 2019
High-Throughput Screening for Drug CombinationsPaul Shinn, Lu Chen, Marc Ferrer, et al.
Chemical Research in Toxicology|November 21, 2017
The Toxmatrix: Chemo-Genomic Profiling Identifies Interactions That Reveal Mechanisms of ToxicityZhi-Bin Tong, Ruili Huang, Yuhong Wang, et al.
ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 29, 2022
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroidsMolly E Boutin, Caroline E Strong, Brittney Van Hese, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
ACS Pharmacology & Translational Science|December 17, 2020
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity AssayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
Journal of Biomolecular Screening|August 21, 2012
Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compoundsThomas Smith, Pei-I Ho, Kim Yue, et al.
Frontiers in Pharmacology|December 12, 2022
Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule librariesMichael H Ronzetti, Bolormaa Baljinnyam, Zina Itkin, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayQuinlin M Hanson, Kelli M Wilson, Min Shen, et al.
ACS Pharmacology & Translational Science|August 15, 2024
A Comprehensive Collection of Pain and Opioid Use Disorder Compounds for High-Throughput Screening and Artificial Intelligence-Driven Drug DiscoveryXin Hu, Paul Shinn, Zina Itkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2021
Deep learning identifies synergistic drug combinations for treating COVID-19Wengong Jin, Jonathan M Stokes, Richard T Eastman, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 9, 2019
High-Throughput Screening for Drug CombinationsPaul Shinn, Lu Chen, Marc Ferrer, et al.
Chemical Research in Toxicology|November 21, 2017
The Toxmatrix: Chemo-Genomic Profiling Identifies Interactions That Reveal Mechanisms of ToxicityZhi-Bin Tong, Ruili Huang, Yuhong Wang, et al.
ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 29, 2022
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroidsMolly E Boutin, Caroline E Strong, Brittney Van Hese, et al.
Pageof 5